Ehlers-Danlos Syndrome (EDS) is a complex condition. This genetic disorder affects the body’s connective tissues, causing a range of symptoms, including most notably, chronic pain.

One of the most challenging aspects of EDS is how debilitating this pain can be, impacting a person’s daily life and overall well-being. In the quest for effective pain management strategies, prolotherapy has emerged as a promising regenerative medicine treatment, which involves a series of injections into affected areas, aiming to stimulate the body’s natural healing process.

This regenerative joint injection therapy uses solutions to stimulate healing and permanently strengthen and repair painful, injured joints – without surgery.